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Introduction
Several epidemiological sources show
that half of all women in western countries
will die of some cardiovascular event, and
since women live longer than men, the ab-
solute number of women dying of cardio-
vascular disease exceeds that of men.
Therefore, diagnosis, treatment and pre-
vention are as important in women as in
men; and yet for many decades women
have been under-diagnosed and under-
treated in all cardiovascular procedures.
There certainly are gender-related dif-
ferences in:
- the risk factor prevalence,
- the disease presentation and natural histo-
ry,
- behavioral and psychosocial factors, qual-
ity of life, communication style, etc.
The global risk profile is important both
in women and in men; nevertheless, dia-
betes is more aggressive, and menopause –
especially when this occurs before age 40-
45 – a unique risk factor in women. On the
other hand, hormone replacement therapy
may be considered as a unique antidote or
as a bias for the evaluation of the natural
history of the disease1, although this issue
is now still widely debated.
The evaluation of chest pain
The evaluation of chest pain is a critical
step in the care of women with heart dis-
ease. Some misconceptions derive from
important studies such as the Framingham
study2, where angina was defined as being
benign when compared to men. The prob-
lems with this study were that angina was
defined using clinical criteria and that the
study group was relatively young.
Another bias derives from the CASS
study3 where the prevalence of coronary
stenosis was 50% in men and 17% in
women. All data were derived from hemo-
dynamic assessments and we now know
that, in virtually every angiographic series,
women with chest pain have a lower preva-
lence of coronary stenosis than men. The
problem with chest pain evaluation in
women is due to the fact that women have:
• “atypical” chest pain, probably because
the present description of the “typical”
symptoms was developed and based on
what referred by male patients;
• silent ischemia and dyspnea as well as di-
astolic dysfunction more frequently than in
men.
Moreover, women tend to be older and
less active than their male counterpart, and
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This review examines the contribution of the literature to the controversial issue of diagnostic
procedures in women affected by coronary artery disease (CAD), on which a large number of pa-
pers have been published. It has been reported that cerebro- and cardiovascular diseases represent
the first cause of death in the New as well as in the Old World, Italy included. Some studies are con-
ditioned by bias; one of these is the Framingham study, in which angina was reported and defined
only clinically and for a relatively young age range, as a benign condition in women. Angiographic
studies, such as the CASS, considered a super elected group of women referred to the hemodynamic
laboratory for chest pain, which in the female gender often has atypical characteristics. In our
opinion, it is mandatory to take into account: 1) what chest pain really means in women; 2) the fact
that there are gender differences: women have a different biological and hormonal status, lifestyle,
and perception of the disease; 3) that there is a different approach of the physicians to a woman
with possible or suspected CAD. We suggest, therefore, a more peculiar and individualized diag-
nostic approach to women suspected as having CAD. This approach should also take the pre-test
probability of disease into consideration. The first investigational step we recommend is the exer-
cise ECG test; should this be unfeasible or not interpretable, an imaging and/or pharmacological
stress test is advisable. In case of positive first test results, coronary angiography should be per-
formed.
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often lack typical effort symptoms. Hence, many au-
thors still believe that coronary artery disease (CAD) is
a “widow maker disease” or a man’s disease.
Taking a closer look at the CASS description of
atypical angina pectoris we easily recognize women
within these characteristics3. CASS defines “atypical”
the pain located in the left or right chest, abdomen, back
or arms in the absence of mid-chest pain; it may be
sharp or fleeting, very prolonged and unrelated to exer-
cise; it may be relieved by antacids, but not by rest or ni-
troglycerin. Moreover, the PIMI study4 included 170
men and 26 women, each with documented CAD;
women reported chest pain more often than men during
their daily activities and during mental stress, but not
during exercise. A higher proportion of women, as com-
pared to men, referred marked pain sensitivity to graded
heat applied to the skin. Another report5 described a
group of 98 patients (51 women) admitted with a diag-
nosis of myocardial infarction and among whom chest
pain was the most common symptom reported by men
and women. Four signs were also identical in both sex-
es: fatigue, rest pain, dyspnea and weakness, but women
also reported a loss of appetite, paroxysmal dyspnea and
back pain. Finally, Everts et al.6 reported on 903 con-
secutive patients admitted to the coronary care unit for
suspected myocardial infarction. According to these au-
thors, women reported neck pain (p < 0.05) and back
pain (p < 0.01) more frequently than men.
Use of diagnostic tests in women with chest pain
We agree with the opinions expressed in a classic
study by Douglas and Ginsburg7 stating that the pre-test
probability of CAD in women is the most important
guide to choose the ideal test. If there is a low likelihood
of CAD (< 20%), no initial or subsequent test is recom-
mended; with a moderate likelihood of CAD (20-80%)
an exercise test should be performed. When the test is
negative, no further investigations are required; in the
presence of an inconclusive or positive exercise test, an
imaging test or a coronary angiography is indicated. Fi-
nally, while a negative imaging stress test is decisive for
the diagnosis, an inconclusive or positive one implies a
coronary angiography. We should recommend the same
aggressive approach to our female patients with a high
likelihood of CAD (> 80%). Douglas’ survey reported
(Table I) the determinants of CAD in American women
and the global risk profile, which does not reflect the
risk we observed in the population of our study8. Our
study involved 862 women (mean age 63 ± 8 years) who
were hospitalized between January 1994 and December
1996 for a first episode of angina. These patients were
divided into two groups: group 1 included 560 patients
with angiographic evidence of CAD and group 2, 302
patients without CAD. At univariate analysis the fol-
lowing characteristics were significantly correlated with
the presence of CAD: 1) age > 65 years (p < 0.0001), 2)
positive rest ECG at least during one episode (p < 0.0001),
and 3) hypertension (p < 0.0001) and diabetes (p < 0.005).
At multivariate analysis, only a positive ECG during an
anginal attack was an independent predictor of CAD. 
Diagnostic test
The standard stress ECG test is reported to be less
accurate in women because of: 1) a lower prevalence of
CAD at any given age, and 2) a possible influence of
autonomic and sex hormones on the ECG.
Given the fact that women are older and that the
achievement of an adequate stress level can be a problem
due to deconditioning or orthopedic limitations, this test
is, in our opinion, the most accurate only when feasible
and easily interpretable. Nonetheless, many studies have
contributed to create skepticism. Sullivan et al.9 reported
on 1570 patients (886 females) referred for chest pain;
23% of women had normal coronary angiograms com-
pared with 41% of men (p < 0.01) and diabetes was the
only risk factor in women with CAD (p < 0.0001). The
specificity and positive predictive value of the exercise
test were significantly lower in women than in men (71
vs 93%, p < 0.001, and 76 vs 95%, p < 0.001, respec-
tively). Again, Curzen et al.10 reported, in 347 women
with chest pain who underwent the ECG test, an overall
low sensitivity (68%) and specificity (61%), with low
positive (61%) and negative (68%) predictive values.
The authors concluded that in 36% of women with chest
pain the use of the ECG test was a misleading predictor
of the presence or absence of CAD. This appears, in our
opinion, a real misleading interpretation of an old, easily
feasible, low-cost, accurate test. Chae et al.11 described
the ECG test and thallium stress scintigraphy as having
the same sensitivity and specificity in women, when the
exercise was well performed and the ECG was clearly in-
terpretable. Women have a notoriously high rate of false
positive exercise tests, but, as demonstrated by Pratt et
al.12 three independent exercise variables are associated
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Table I. Determinants of coronary heart disease (CHD) in
women with chest pain.
Major
Typical angina
Postmenopausal status without HRT
Peripheral vascular disease
Diabetes
Intermediate
LDL cholesterol levels
Hypertension
Smoking
Minor
Age > 65 years
Central obesity (waist to hip ratio > 0.9)
Sedentary lifestyle
Family history of CHD
HRT = hormone replacement therapy.
with a high likelihood of CAD: an exercise duration
< 5 min, the inability to reach the target heart rate, and a
time to ST-segment normalization ≥ 6 min. The ST-T
change (91%) and a low maximum workload (84%) at
the exercise test were reported by our group to have a
high positive predictive value in women.
Imaging stress test
Women are under-represented in studies on the
imaging stress test. Gender specific artifacts and phys-
iological responses have been described in both nuclear
and echocardiographic studies. The pre-test likelihood
of disease is probably more important than the type of
stress test for women just as and more than for men.
Dipyridamole thallium-201 was described by Shaw et
al.13 to have a lower sensitivity and a much lower speci-
ficity in women compared to men (43 women and 71
men with angina pectoris), with less sensitivity for one
vessel disease. With regard to stress echocardiography
it appears in some reports to be very accurate in
women. Davar et al.14 described 135 women with a
high pre-test probability of CAD. These were investi-
gated by treadmill or dobutamine stress echo, with a
mean follow-up of 20 months. Cox analysis revealed a
positive stress echo as a unique predictor of future
events (relative risk 8.9, confidence interval 1.0-76.5,
p = 0.04). In this experience a negative stress echo test
identified a subgroup of women with a low risk of car-
diac events, and a positive stress echo a subgroup with
an increased risk of events. Cortigiani et al.15 investi-
gated the prognostic value of pharmacological stress
echocardiography in 456 women referred for chest
pain, and unknown CAD. In that group of patients, the
test proved to be safe and highly feasible for risk strat-
ification. All these different, sometimes confusing re-
sults are the consequence of the approach of doctors to
women with chest pain, characterized by a higher num-
ber of test requests in comparison to male patients. In
conclusion, starting from the misconception that
women have a lower probability of CAD, physicians
feel justified in recommending all feasible tests rather
than running the risk of a mistaken diagnosis. The con-
sequence is that of non-homogeneous results in test
sensitivity and specificity in women. 
To test the accuracy of different tests, some years
ago we studied16 200 patients (100 males, mean age 60
± 6 years) who were hospitalized in the coronary care
unit for a first episode of “definite” angina. All patients
underwent coronary angiography and different stress
tests before angiography: 1) dobutamine stress echo-
cardiography: 42 males and 40 females; 2) stress thal-
lium: 18 males and 17 females; and 3) the exercise test:
48 males and 52 females. Our results (Table II) revealed
a very low sensitivity and specificity of all the tests in
women, whereas dobutamine stress echocardiography
was the most accurate test in men.
Conclusions
Our experience allows some recommendations for a
correct non-invasive evaluation in women. If the end-
point of the diagnosis is the localization of ischemia,
we recommend imaging techniques associated with
stress testing. The choice of the imaging modality to be
used should depend on the expertise of the individual
institute. If the endpoint is the diagnosis of ischemia,
we suggest an evaluation of the pre-test probability of
the disease on the basis of the guidelines summarized in
table III in which our own approach is outlined.
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Table II. Comparison of three different non-invasive tests between females and males with coronary artery disease.
DSE STS ECG test
Females Males Females Males Females Males
Sensitivity (%) 67 87* 69 80** 65 77**
Specificity (%) 72 98* 60 93** 58 90**
DSE = dobutamine stress echocardiography; STS = stress thallium scintigraphy. * p < 0.001; ** p < 0.01.
Table III. Diagnostic work-up guidelines.
Pre-test probability of disease Low
No test
Pre-test probability of disease Intermediate
- interpretable ECG, possible exercise Exercise test
- uninterpretable ECG, possible exercise Exercise echocardiography or sestamibi
- uninterpretable ECG, impossible exercise Stress pharmacological with echo or sestamibi (or thallium)
Pre-test probability of disease High
Coronary angiography
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